제노켐코리아

비상장계속사업자

ZENOCHEM KOREA LTD

박현서

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

제노켐코리아

Business Reg. No. 1058662116 · CEO 박현서

I.Investment Overview

Target제노켐코리아 (1058662116)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명제노켐코리아
영문명ZENOCHEM KOREA LTD
대표자박현서
사업자등록번호1058662116
법인등록번호1101112920084
설립일2003.12.23

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW112.32021109.32022119.42023127.92024127.62025
영업이익100M KRW14.3202111.620228.1202315.420247.72025
순이익100M KRW24.2202111.9202214.9202316.9202418.12025
Item20252024202320222021
자산총계282.8억원263.7억원280억원292.6억원288.1억원
부채총계38.3억원39.6억원67.8억원64.5억원71.7억원
자본총계244.6억원224.1억원212.3억원228.1억원216.3억원
매출액127.6억원127.9억원119.4억원109.3억원112.3억원
영업이익7.7억원15.4억원8.1억원11.6억원14.3억원
순이익18.1억원16.9억원14.9억원11.9억원24.2억원

VI.Financial Ratios

FY2025 basis

6.03%

영업이익률

14.18%

순이익률

6.4%

ROA

7.4%

ROE

15.65%

부채비율

86.47%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

제노켐코리아 투심보고서 | Alpha Lenz